三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
针对肝癌目前1L/2L治疗方案的ORR较低,mPFS较短,依帕戈替尼(ABSK011)有望改变这一状况
针对肝癌目前1L/2L治疗方案的ORR较低,mPFS较短,依帕戈替尼(ABSK011)有望改变这一状况
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:491KB
图片尺寸:2317*995
同报告图片
/
4
PHxiZWdpbl9vZl9ib3h8Pnwg5rK755aX57q/IHwg5rK755aX57G75YirICAgICAgICAgICAgICAgfCDoja/nianlkI3np7AgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgT1JSICAgICAgIHwgbVBGUy9QRlMgICB8IG1PUyAgICAgICAgIHwg5YW25LuW5aSH5rOoICAgICAgICAgICAgICAgICAgICAgfAp8LS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAxc3QgTGluZSB8IE11bHRpLVRLSXMgICAgICAgICAgICAgfCBTb3JhZmVuaWIsIExlbnZhdGluaWIgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDItMTklICAgICB8IDUuNSDigJMgNy4zbSB8IDEwLjctMTMuNm0gIHwgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMXN0IExpbmUgfCBJbW11bm8tVGhlcmFwaWVzICAgICAgIHwgQXRlem9saXp1bWFiICsgYmV2YWNpenVtYWLjgIFUcmVtZWxpbXVtYWIgKyBkdXJ2YWx1bWFiICAgICAgICAgICAgICAgICAgICB8IDIwLTMwJSAgICB8IDMuOCDigJMgNi45bSB8IDE2LjQg4oCTIDE5LjJtfCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwKfCAxc3QgTGluZSB8IFByaW9yIEZHRlI0IEluaGliaXRvcnMgfCBCbHU1NTQgKEJsdWVwcmludC9Dc3RvbmUpICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDM2JSAoNC8xMSl8ICAgICAgICAgICAgfCAgICAgICAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDFzdCBMaW5lIHwgQWJiaXNrbyBGR0ZSNCBJbmhpYml0b3J8IElycGFncmF0aW5pYiBDb21iaW5hdGlvbnMgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgICAgICAgICAgIHwgICAgICAgICAgICB8ICAgICAgICAgICAgIHwgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8CnwgMm5kIExpbmUgfCBNdWx0aS1US0lzICAgICAgICAgICAgIHwgUmVnb3JhZmVuaWIsIENhYm96YW50aW5pYiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIHwgNC03JSAgICAgIHwgMy40IOKAkyA1LjJtIHwgMTAuMiDigJMgMTAuNm18ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDJuZCBMaW5lIHwgSW1tdW5vLVRoZXJhcGllcyAgICAgICB8IFBlbWJyb2xpenVtYWIgKE5pdm9sdW1hYiArIElwaWxpbXVtYWIqKSAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICB8IDE4JSAgICAgICB8IDQuOW0gICAgICAgfCAxMy4ybSAgICAgICB8ICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfAp8IDJuZCBMaW5lIHwgUHJpb3IgRkdGUjQgSW5oaWJpdG9ycyB8IEJsdTU1NCAoQmx1ZXByaW50L0NzdG9uZSnjgIFGR0Y0MDEgKE5vdmFydGlzKeOAgUgzQi02NTI3IChIMy9FaXNhaSkgICAgICAgIHwgNy0xNiUgICAgIHwgU2hvcnQgUEZTICB8ICAgICAgICAgICAgIHwgVW5kZXNpcmVkIHNhZmV0eSBwcm9maWxlICAgICB8CnwgMm5kIExpbmUgfCBBYmJpc2tvIEZHRlI0IEluaGliaXRvcnwgSXJwYWdyYXRpbmliICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgfCA0NC44JSAgICAgfCA1LjVtICAgICAgIHwgICAgICAgICAgICAgfCBTdXBlcmlvciBzYWZldHkgcHJvZmlsZSAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuFBQVO+8m+WFtuS4reaYvuekuueahDQ0LjglIE9SUuS4uuS4tOW6iuS4gOacn+ivlemqjOe7k+aenOOAgjx8ZW5kX29mX2JveHw+
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
fCDpobnnm64gICAgICAgICAgICAgICAgfCDkuK3lm70gICAgICAgICAgfCDnvo7lm70gICAgICAgICAgfCDkuK3nvo7lkIjorqEgICAgICAgIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tfAp8IOW5tOWPkeeXheeOhyAgICAgICAgICAgIHwgfjYwLDAwMCAgICAgICB8IH4xNCwwMDAgICAgICAgfCDigJQgICAgICAgICAgICAgICB8Cnwg5ZWG5Lia5r2c5Yqb77yIVVMk77yJICAgICB8IH5VUyQ2NTBtICAgICAgfCB+VVMkODUwbSAgICAgIHwgflVTJDEuNWJuICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuOi1hOaWmQ==
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
所属报告:
和誉(2256.HK)-港股公司首次覆盖:中国小分子新药研发标兵迎接商业化转型元年-251002(44页).pdf
打包全文图表
相关数据
图表12一线尿路上皮癌不同疗法mPFS(月)对比
fCDnlpfms5Xlr7nmr5QgICAgICAgICAgfCDogZTlkIjnlpfms5XvvIjmnIjvvIkgfCDlr7nnhafvvIjmnIjvvIkgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwKfCBLK+S7keS8kCB2cyBLICAgICAgIHwgNC4yICAgICAgICAgICAgfCA0LjAgICAgICAgIHwKfCBLK+WMlueWlyB2cyDljJbnlpcgICAgfCA4LjMgICAgICAgICAgICB8IDcuMiAgICAgICAgfAp8IE8rWStTRyAgICAgICAgICAgIHwgOC45ICAgICAgICAgICAgfCAtICAgICAgICAgIHwKfCBLK0VWIHZzIOWMlueWlyAgICAgIHwgMTIuNiAgICAgICAgICAgfCA2LjQgICAgICAgIHwKCui1hOaWmeadpea6kO+8mkhvaW1lcywgQy4gSi4sIFJvc2VuYmVyZywgSi4gRS4sICYgUGV0cnlsYWssIEQuIFAuICgyMDIwKS4=
收藏
行业数据
2026-02-28
原图定位
查看详情
图表13一线TNBC不同疗法ORR对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
图表11一线尿路上皮癌不同疗法ORR对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
图表14一线TNBC不同疗法mPFS(月)对比
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
收藏
行业数据
2026-02-28
原图定位
查看详情
SI-B001针对PD-(L1)抑制剂治疗失败的野生型NSCLC的mPFS数据
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
收藏
行业数据
2025-12-26
原图定位
查看详情
同靶点药物ABBV-085的I期临床展现初步疗效,UPS或肉瘤中ORR=20%
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
收藏
行业数据
2025-12-15
原图定位
查看详情
HARMONi-6在全人群及各个亚组中均展现显著mPFS获益
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
收藏
行业数据
2025-10-23
原图定位
查看详情
DB-1305铂耐药卵巢癌联合方案ORR为53.8%,安全性可控
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
收藏
行业数据
2025-10-23
原图定位
查看详情
全球首个FGFR4抑制剂联合IO在HCC的临床设计:依帕戈替尼联合阿替利珠单抗的临床二期试验方案
PHxiZWdpbl9vZl9ib3h8PnwgUGFydCB8IERvc2UgUmVnaW1lbiAgICAgICB8IFNhbXBsZSBTaXplIChOKSB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS18CnwgQSAgICB8IDE4MG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDMyMG1nIFFEICAgICAgICAgICB8IDYgICAgICAgICAgICAgICB8CnwgQSAgICB8IDE2MG1nIEJJRCAgICAgICAgICB8IDggICAgICAgICAgICAgICB8CnwgQSAgICB8IDIyMG1nIEJJRCAgICAgICAgICB8IDMzICAgICAgICAgICAgICB8CgrotYTmlpnmnaXmupDvvJrlhazlj7hQUFQ8fGVuZF9vZl9ib3h8Pg==
收藏
行业数据
2025-10-10
原图定位
查看详情
全球几款早于和誉依帕戈替尼进入临床阶段的FGFR4抑制剂,大部分都已经停止开发
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
收藏
行业数据
2025-10-10
原图定位
查看详情
全球约30%的肝细胞癌患者存在异常的FGF19-FGFR4通路改变,依帕戈替尼(ABSK011)的独特设计MoA
fCDlnLDljLogICB8IOavj+W5tOaWsOWinueXheS+i+aVsCB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfAp8IOWFqOeQgyAgIHwg57qmMzDkuIcgICAgICAgICB8Cnwg5Lit5Zu9ICAgfCDnuqYxNeS4hyAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWFrOWPuFBQVO+8jOS+neW4leaIiOabv+WwvOmAmui/h+mdtuWQkUZHRjE5IC0gRkdGUjQg6YCa6Lev5rK755aX6IKd55mM
收藏
行业数据
2025-10-10
原图定位
查看详情
TNBC不论PD-L1表达的状况下,依沃西单抗及PM8002在ORR数据以及安全性数据上都显示出优效
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
收藏
行业数据
2025-07-17
原图定位
查看详情
从早期临床数据可见,PD-(L)1/VEGF布局SCLC潜力大、ORR数据亮眼
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
收藏
行业数据
2025-07-17
原图定位
查看详情
无明确驱动基因NSCLC(无论PD-L1表达状态),依沃西PFS数据佳,SSGJ-707的ORR及安全性佳
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
收藏
行业数据
2025-07-17
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
和誉认为,FGF19过表达可能是HCC复发和预后较差的生物标记物,且在接受一线靶免综合治疗的患者中,相较阴性患者,FGF19过表达患者的治疗结局不佳。因此,FGF19过表达检测可能成为针对肝癌特异性的重要生物标记物。 2025年ASCO-GI中披露了ABSK-011-201 trial (NCT05441475),关于依帕戈替尼(FGFR4抑制剂ABSK011)联合阿替利珠单抗(PD-L1)在FGF19高表达的HCC患者中,展示出来更高的应答率(50%以上)和mPFS(>7m),有望改善2L HCC治疗。
行业数据
原图定位
当前图表所属:
和誉(2256.HK)-港股公司首次覆盖:中国小分子新药研发标兵迎接商业化转型元年-251002(44页).pdf
全球三款CSF-1R抑制剂在国际多中心注册性临床开发的速度对比
TGCT腱鞘巨细胞瘤的治疗
腱鞘巨细胞瘤临床举例以及中美流行病学大致情况
和誉截至2025年9月的临床管线示意
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》